Abstract
Patients from the Piemonte and Valle d’Aosta registry for ALS (PARALS) diagnosed between 1995 and 2022 were considered.3 Residential histories were reconstructed from 1990 to symptom onset using municipal records, allowing us to identify buildings where two or more patients lived. Patients residing only in Valle d’Aosta were excluded. Familial cases and those with pathogenetic variants in SOD1, TARDBP, C9orf72 or FUS genes were also excluded to focus on common environmental exposures.
Funding Information
  • Italian Ministry of Health (PNRR-MAD-2022-12375731, RF-2016-02362405)
  • Italian Ministry of Education, University and Research (2017SNW5MB, 20228N7573)
  • European Union’s Horizon 2020 (101137074, GA101017598)
  • European Commission’s Health Seventh Framework Programme (FP7/2007-2013 under grant agreement 259867)